Social enterprises are judged by both their social impact and their ability to thrive as financially sustainable businesses. Unfortunately many, if not most, attempts at replicating successful social enterprises have failed. Two experts from the Miller Center for Social Entrepreneurship examine assumptions about what both “success” and “replication” mean with respect to social enterprises.Full Story»
Columnist Gael O’Brien thinks corporate citizenship may be entering its greatest test. Will a Trump presidency have the effect of muting CEO voices for fear of reprisals and Twitter attacks in a government now controlled by one political party? Or will corporate citizenship, acting out of a bigger sense of purpose, gain increased public trust and support?
When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.
Since the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, American law has required publicly traded companies to detail their sources of so-called “conflict minerals.. Academic research finds that almost 80 percent of firms were unable to determine the sources of the minerals in their products while only one percent could certify their products free of conflict minerals “with great certainty.”
More in this category
- Testing an Organization’s Purpose in the Face of Adversity
- Spotlight on Whole Foods CEO’s Ties to ‘Spiritual Leader with Troubled Past’
- It’s Not Easy: The Challenge of Paying Employees a $70,000 Minimum Salary
- Why More Companies Are Speaking Out on Social Issues
- Leadership: Bold New Programs Need Strong Foundations
- Does Corporate Social Responsibility Increase Profits?